A stable cell line expressing the GRA16 protein for HepG2 and Hep3B, which are p53‐wild‐ and p53‐null type, respectively, as human HCC cells was established to determine the role of GRA16 as an HAUSP inhibitor in cancer cells (Figure 1). Here, TP53 is linked to hepatocellular carcinoma.